PHARMACTIVE BIOTECH PRODUCTS S.L. – Trademark Portfolio
Entity Type: 99
PHARMACTIVE BIOTECH PRODUCTS S.L. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 1 is pending. Notable registered marks include AFFRON, GARLACE, LIBOOST, AFFRONEYE, and LEPTICROSALIDES.
C/ Faraday, 7
E-28049 Madrid
Showing of trademarks Trademarks
Trademark Classifications
PHARMACTIVE BIOTECH PRODUCTS S.L.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PHARMACTIVE BIOTECH PRODUCTS S.L. have?
PHARMACTIVE BIOTECH PRODUCTS S.L. has 14 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 pending, 3 abandoned.
What trademark classes does PHARMACTIVE BIOTECH PRODUCTS S.L. file in?
PHARMACTIVE BIOTECH PRODUCTS S.L. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PHARMACTIVE BIOTECH PRODUCTS S.L.'s most well-known trademarks?
PHARMACTIVE BIOTECH PRODUCTS S.L.'s registered trademark portfolio includes well-known marks such as AFFRON, GARLACE, LIBOOST, AFFRONEYE, and LEPTICROSALIDES. These are among 6 currently registered trademarks in the portfolio.
What is PHARMACTIVE BIOTECH PRODUCTS S.L.'s trademark registration success rate?
PHARMACTIVE BIOTECH PRODUCTS S.L. has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 1 application is pending review.